Status:

RECRUITING

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Lead Sponsor:

National Cancer Institute (NCI)

Conditions:

Neuroendocrine Tumors

Carcinoma, Neuroendocrine

Eligibility:

All Genders

18-120 years

Brief Summary

Background: Neuroendocrine neoplasm (NENs)are rare cancers arising from the neuroendocrine cells and can affect almost any part of the body. They vary from low grade neuroendocrine tumors (NETs) to h...

Detailed Description

Background: * Neuroendocrine neoplasms (NENs) are divided into neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). These are rare malignancies occurring for example in the gastrointest...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Age \>= 18 years old
  • The ability of the participant to understand and the willingness to sign a written consent document.
  • Participants with the documentation of:
  • histological or cytological confirmation of NENs or adrenocortical cancer
  • OR
  • -biochemical evidence of neuroendocrine tumor (serum/urinary) based on elevated levels of chromogranin A, pancreatic polypeptide, neuron-specific enolase, vasoactive intestinal polypeptide, serotonin (urinary 5-hydroxyindoleacetic acid (5-HIAA)), gastrin, somatostatin, catecholamines, metanephrines, calcitonin, fasting insulin, Cpeptide (proinsulin), glucagon, anterior pituitary hormones
  • OR
  • -Suspicion of NEN (from any site/origin) on axial imaging (computed tomography (CT)/ magnetic resonance imaging (MRI) / fluorodeoxyglucose (FDG) positron emission tomography (PET) / 68Ga-Dotatate scan
  • OR
  • -a germline genetic variant that predisposes to NETs including ACC.
  • EXCLUSION CRITERIA:
  • None

Exclusion

    Key Trial Info

    Start Date :

    April 25 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2032

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT05237934

    Start Date

    April 25 2022

    End Date

    December 31 2032

    Last Update

    November 12 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892